1. MAPK/ERK Pathway PI3K/Akt/mTOR Metabolic Enzyme/Protease
  2. MEK PI3K Endogenous Metabolite
  3. Isorhamnetin

Isorhamnetin  (Synonyms: 3'-Methylquercetin)

Cat. No.: HY-N0776 Purity: 99.74%
Handling Instructions Technical Support

Isorhamnetin is a flavonoid compound extracted from the Chinese herb Hippophae rhamnoides L.. Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3K.

For research use only. We do not sell to patients.

CAS No. : 480-19-3

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
1 mg In-stock
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 17 publication(s) in Google Scholar

Other Forms of Isorhamnetin:

Top Publications Citing Use of Products

    Isorhamnetin purchased from MedChemExpress. Usage Cited in: Invest Ophthalmol Vis Sci. 2021 Mar 1;62(3):38.  [Abstract]

    Fumigatus conidia were cultured with 0.5% DMSO and Isorhamnetin at different concentrations (5–320 μg/mL) for 48 hours. Isorhamnetin started to inhibit the growth of A. fumigatus at 10 μg/mL and prevented 90% of A. fumigatus growth (MIC90) at 80 μg/mL.

    Isorhamnetin purchased from MedChemExpress. Usage Cited in: Invest Ophthalmol Vis Sci. 2021 Mar 1;62(3):38.  [Abstract]

    Hyphae treated with 0.5% DMSO showed an intact morphological structure characterized by smooth surface and rounded mycelia. Isorhamnetin (80 μg/mL; 24 h) treatment caused the hyphae of A. fumigatus to become thinner, swollen, twisted, and knotted.

    Isorhamnetin purchased from MedChemExpress. Usage Cited in: Invest Ophthalmol Vis Sci. 2021 Mar 1;62(3):38.  [Abstract]

    Representative slit lamp photographs and clinical scores of DMSO or Isorhamnetin (5 µL; 80 µg/mL; four times daily for five days) treated A. fumigatus keratitis mice at days 1, 3, and 5. Isorhamnetin treatment made the corneas of mice more transparent, with smaller ulcers and no perforation, and also significantly decreased the clinical score at 3 and 5 days.

    Isorhamnetin purchased from MedChemExpress. Usage Cited in: Invest Ophthalmol Vis Sci. 2021 Mar 1;62(3):38.  [Abstract]

    PAS staining of corneal tissue sections (magnification × 400) of DMSO or Isorhamnetin (5 µL; 80 µg/mL; four times daily for five days) treated. Isorhamnetin observably reduced fungal hyphal load and alleviated corneal edema in A. fumigatus–infected mice on the third day after.

    Isorhamnetin purchased from MedChemExpress. Usage Cited in: Invest Ophthalmol Vis Sci. 2021 Mar 1;62(3):38.  [Abstract]

    Western blot results and grayscale analysis of TLR-2, TLR-4, Dectin-1 at 3 days p.i. Isorhamnetin (5 µL; 80 µg/mL; four times daily) significantly inhibited A. fumigatus induction of TLR-2, TLR-4 and Dectin-1 in protein level.
    • Biological Activity

    • Protocol

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Isorhamnetin is a flavonoid compound extracted from the Chinese herb Hippophae rhamnoides L.. Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3K.

    IC50 & Target[1]

    MEK1

     

    PI3-K

     

    Human Endogenous Metabolite

     

    Cellular Effect
    Cell Line Type Value Description References
    HUVEC IC50
    2.8 μM
    Compound: 39, isorhamnetin
    Inhibition of NADPH oxidase in Homo sapiens (human) HUVEC cells
    Inhibition of NADPH oxidase in Homo sapiens (human) HUVEC cells
    10.1007/s00044-012-0353-y
    HeLa IC50
    8.1 μM
    Compound: Isorhamnetol
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    [PMID: 31784199]
    HeLa IC50
    >= 10 μM
    Compound: isorhamnetin
    Cytotoxicity against human HeLa cells by MTT assay
    Cytotoxicity against human HeLa cells by MTT assay
    [PMID: 19278239]
    Huh-7 CC50
    > 50 μM
    Compound: 27
    Cytotoxicity against human Huh7.5.1 cells by MTT assay
    Cytotoxicity against human Huh7.5.1 cells by MTT assay
    [PMID: 22445328]
    MCF7 IC50
    10.3 μM
    Compound: Isorhamnetol
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
    [PMID: 31784199]
    Monocyte IC50
    3.8 x 10-6 M
    Compound: isorhamnetin
    Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs
    Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs
    [PMID: 8882428]
    N9 IC50
    17.87 μM
    Compound: 1
    Antineuroinflammatory activity in mouse N9 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay
    Antineuroinflammatory activity in mouse N9 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay
    [PMID: 28073678]
    In Vitro

    Isorhamnetin is a plant flavonoid that occurs in fruits and medicinal herbs. Isorhamnetin binds directly to MEK1 in an ATP-noncompetitive manner and to PI3-K in an ATP-competitive manner. In vitro and ex vivo kinase assay data show that Isorhamnetin inhibits the kinase activity of MAP/ERK kinase (MEK) 1 and PI3-K and the inhibition is due to direct binding with Isorhamnetin[1]. Isorhamnetin inhibits the Akt/mTOR and MEK/ERK signaling pathways, and promotes the activity of the mitochondrial apoptosis signaling pathway. The inhibitory effects of Isorhamnetin on breast cancer cells are determined using the CCK-8 method. Isorhamnetin inhibits the proliferation of numerous breast cancer cells (IC50, ~10 μM), including MCF7, T47D, BT474, BT-549, MDA-MB-231 and MDA-MB-468, whereas less inhibitory activity is observed in the MCF10A normal breast epithelial cell line (IC50, 38 μM)[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Photographic data shows that Isorhamnetin treatment suppresses tumor development in mice. The average volume of tumors in untreated mice increases over time and reaches a volume of 623 mm3 at 4 weeks post-inoculation; however, at this time, in mice treated with 1 or 5 mg/kg Isorhamnetin, the average tumor volume is only 280 or 198 mm3, respectively. At the end of the study, Isorhamnetin treatment (1 or 5 mg/kg) reduces tumor weight compared with the untreated control group[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Molecular Weight

    316.26

    Formula

    C16H12O7

    CAS No.
    Appearance

    Solid

    Color

    Light yellow to yellow

    SMILES

    O=C1C(O)=C(C2=CC=C(O)C(OC)=C2)OC3=CC(O)=CC(O)=C13

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 1 year
    -20°C 6 months
    Solvent & Solubility
    In Vitro: 

    DMSO : 100 mg/mL (316.20 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.1620 mL 15.8098 mL 31.6196 mL
    5 mM 0.6324 mL 3.1620 mL 6.3239 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: 2.08 mg/mL (6.58 mM); Suspended solution; Need ultrasonic

      This protocol yields a suspended solution of 2.08 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.94%

    References
    Cell Assay
    [2]

    MCF7, T47D, BT474, BT-549, MDA-MB-231 and MDA-MB-468 breast cancer cell lines, as well as a MCF10A normal breast epithelial cell line (control) are seeded into 96-well plates at a density of 5×103 cells/well in 100 µL DMEM and placed in cell incubator for 12 h at 37°C in an atmosphere containing 5% CO2. The cells are then treated with various concentrations of Isorhamnetin (100, 33.3, 11.1, 3.7, 1.2, 0.4 and 0 µM) for 48 h, and cell proliferation rates are determined by adding 10 µL CCK-8 solution prior to incubation at 37°C for 2 h. The absorbance is measured at a wavelength of 450 nm using a SpectraMax 190 Microplate Reader. For each assay, four parallel wells are included, and the half maximal inhibitory concentration (IC50) is measured using the inhibition curve and presented as the mean of three independent experiments[2].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Administration
    [1]

    Mice[1]
    Female athymic nude mice are injected subcutaneously in the flank with A431 cells (1×106 cells in 50 μL of medium and 50 μL of Matrigel). Cells are allowed to form tumors, and once the tumors reach a size of 40 mm3, the mice are randomly assigned into groups (6 mice/group) and treated with (1 or 5 mg/kg body weight) or without Isorhamnetin in 40% DMSO/PBS buffer, administered intraperitoneally every other day for 28 days. Tumor size is measured every week with calipers, and the tumor volume is calculated. Mice are sacrificed after 28 days of treatment when the control tumors reach approximately 600 mm3. The tumors are harvested, photographed, and weighed. Tumor tissues are used for western blot analysis and immunohistochemical analysis.

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 3.1620 mL 15.8098 mL 31.6196 mL 79.0489 mL
    5 mM 0.6324 mL 3.1620 mL 6.3239 mL 15.8098 mL
    10 mM 0.3162 mL 1.5810 mL 3.1620 mL 7.9049 mL
    15 mM 0.2108 mL 1.0540 mL 2.1080 mL 5.2699 mL
    20 mM 0.1581 mL 0.7905 mL 1.5810 mL 3.9524 mL
    25 mM 0.1265 mL 0.6324 mL 1.2648 mL 3.1620 mL
    30 mM 0.1054 mL 0.5270 mL 1.0540 mL 2.6350 mL
    40 mM 0.0790 mL 0.3952 mL 0.7905 mL 1.9762 mL
    50 mM 0.0632 mL 0.3162 mL 0.6324 mL 1.5810 mL
    60 mM 0.0527 mL 0.2635 mL 0.5270 mL 1.3175 mL
    80 mM 0.0395 mL 0.1976 mL 0.3952 mL 0.9881 mL
    100 mM 0.0316 mL 0.1581 mL 0.3162 mL 0.7905 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Isorhamnetin
    Cat. No.:
    HY-N0776
    Quantity:
    MCE Japan Authorized Agent: